Proteolytic elimination of decay-accelerating factor (DAF): Lytic abnormality coincides with removal of DAF in papain-treated human erythrocytes
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 27 (1), 69-78
- https://doi.org/10.1016/0161-5890(90)90061-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteinsNature, 1987
- Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1987
- Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipidBiochemistry, 1986
- Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteinsImmunology Today, 1986
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.Journal of Clinical Investigation, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- The biochemistry of complementNature, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970